Building a Strong European Health Union: Blazing a trail in the European pharmaceutical sector
The start of the decade has crystallised the importance of healthcare policy, particularly due to the COVID-19 pandemic. This global
Read more
Research & Innovation
A critical medicines act for Europe
Introduction Over the past few decades, Europe’s manufacturing base for off-patent medicines, APIs, and starting materials has gradually decreased. This
Read more
Rethinking the EU general pharmaceutical legislation for a competitive, more resilient and healthier Europe
As discussions surrounding the revision of the EU pharmaceutical legislation take place, two fundamental questions come to the forefront: how
Read more
New EU pharmaceuticals rules in a strong European Health Union
Since 2020, the COVID pandemic altered every part of our lives, our societies, and our economies. It caught the world
Read more
The lessons EU learned from the pandemic towards a better prepared and resilient pharmaceutical system
The COVID-19 crisis has pushed health higher on the agenda of the European Union, but also on the list of
Read more
“Act” as “Action” – The Critical Raw Materials Act is the fundament of a transforming industry in Europe
A lot has changed in the last two years. The pandemic and the war in Ukraine have made us feel
Read more
Next stop: political innovation
Governments can exercise their power in two main ways: on the one hand, by imposing rules and regulations, and on
Read more
Power deep tech innovation for a net-zero economy
The race is on. Countries all over the world are competing for new technology to protect their industries, while mitigating
Read more